The BID Learning Network recently held a webinar called "Successful implementation of a Health information Software." In this webinar, the speakers shared Mali’s experience implementing health information software. The presentation took the...

This fact sheet describes PATH’s efforts to eliminate meningococcal meningitis epidemics from Africa, once and for all. It covers work across meningitis projects, including the development and distribution of MenAfriVac®, the vaccine that has...

Background: In preparation for the introduction of MenAfriVac, a meningococcal group A conjugate vaccine developed for the African meningitis belt, an enhanced meningitis surveillance network was established. We analysed surveillance data on...

Background: Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in...

Background Significant progress has been made to increase access to vaccines in Africa since the 1974 launch of the Expanded Programme on Immunization (EPI). Successes include the introduction of several new vaccines across the continent and...

Background Despite the heightened risk of serious influenza during infancy, vaccination is not recommended in infants younger than 6 months. We aimed to assess the safety, immunogenicity, and efficacy of maternal immunisation with trivalent...

In 1986, the Government of Mali launched its Expanded Program on Immunization (EPI) with the goal of vaccinating, within five years, 80% of all children under the age of five against six target diseases: diphtheria, tetanus, pertussis,...

Vaccination coverage surveys - Publication abstract: BACKGROUND: Estimation of vaccination coverage at the local level is essential to identify communities that may require additional support. Cluster surveys can be used in resource-poor...

This report highlights the achievements made in expanding access to vaccines in Africa and discusses some of the remaining challenges to achieving universal access to vaccines. The timing of this report coincides with the halfway point of the...